Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value of <i>RASSF1</i> Promoter Methylation in Prostate Cancer

26 Jun 2014

Abstract excerpt

PURPOSE: Patients with prostate cancer who have biochemical recurrence after curative therapy are at higher risk for distant metastasis and cancer specific death. Assessment of aberrant DNA methylation in urine might complement currently used clinical prognostic factors and serve as a noninvasive tool for early prediction of biochemical recurrence after radical prostatectomy. MATERIALS AND METHODS: Promoter...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24980613
DOI: 10.1016/j.juro.2014.06.075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value of <i>RASSF1</i> Promoter Methylation in Prostate CancerPMID 24980613Read ↗

The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.Semantic proximity Read ↗

Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis.Semantic proximity Read ↗

DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detectionSemantic proximity Read ↗

Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.Semantic proximity Read ↗

DNA methylation alterations in prostate cancer: from diagnosis to treatmentSemantic proximity Read ↗

The emerging roles of DNA methylation in the clinical management of prostate cancerSemantic proximity Read ↗

Global Methylation Profiling for Risk Prediction of Prostate CancerSemantic proximity Read ↗

Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.Semantic proximity Read ↗

DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsSemantic proximity Read ↗

Frequent hypermethylation of promoter region of <i>RASSF1A</i> in tumor tissues and voided urine of urinary bladder cancer patientsSemantic proximity Read ↗

DNA methylation changes in prostate cancer: current developments and future clinical implementationSemantic proximity Read ↗

DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.